Palivizumab prevents RSV and reduces later wheezing in preterm infants, but at high cost

Palivizumab prevents RSV and reduces later wheezing in preterm infants, but at high cost is a topic covered in the EE+ POEM Archive.

To view the entire topic, please sign in or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

20 mcg versus >20 mcg estrogen combined oral contraceptives for contraception

"Snowball fingers" - Image

Botulinum toxin for the treatment of strabismus: Cochrane systematic review

ACC/AHA: Fewer patients require prophylaxis for endocarditis

Citation

Barry, Henry, et al., editors. "Palivizumab Prevents RSV and Reduces Later Wheezing in Preterm Infants, but at High Cost." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/427850/all/Palivizumab_prevents_RSV_and_reduces_later_wheezing_in_preterm_infants__but_at_high_cost.

Palivizumab prevents RSV and reduces later wheezing in preterm infants, but at high cost. In: Barry H, Ebell MH, Shaughnessy AF, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/427850/all/Palivizumab_prevents_RSV_and_reduces_later_wheezing_in_preterm_infants__but_at_high_cost. Accessed January 22, 2019.

Palivizumab prevents RSV and reduces later wheezing in preterm infants, but at high cost. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. Available from https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/427850/all/Palivizumab_prevents_RSV_and_reduces_later_wheezing_in_preterm_infants__but_at_high_cost

Palivizumab Prevents RSV and Reduces Later Wheezing in Preterm Infants, but at High Cost [Internet]. In: Barry H, Ebell MH, Shaughnessy AF, Slawson DC, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2019 January 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/427850/all/Palivizumab_prevents_RSV_and_reduces_later_wheezing_in_preterm_infants__but_at_high_cost

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case

TY - ELEC T1 - Palivizumab prevents RSV and reduces later wheezing in preterm infants, but at high cost ID - 427850 ED - Barry,Henry, ED - Ebell,Mark H, ED - Shaughnessy,Allen F, ED - Slawson,David C, BT - EE+ POEM Archive UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/427850/all/Palivizumab_prevents_RSV_and_reduces_later_wheezing_in_preterm_infants__but_at_high_cost PB - John Wiley & Sons DB - Evidence Central DP - Unbound Medicine ER -